Innoviva, Inc. (INVA)
23.14
-0.27
(-1.15%)
USD |
NASDAQ |
Feb 24, 14:25
Innoviva Total Liabilities (Quarterly) : 419.16M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co., Inc. | -- |
| Nektar Therapeutics | 216.26M |
| Regeneron Pharmaceuticals, Inc. | 9.302B |
| Oramed Pharmaceuticals, Inc. | 18.16M |
| Theravance Biopharma, Inc. | 182.78M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.429B |
| Shareholders Equity (Quarterly) | 1.010B |
| Debt to Equity Ratio | 0.2564 |
| Current Ratio | 14.12 |
| Net Debt Paydown Yield | 2.81% |